Sudha
Seshadri, MD

Dr. Sudha Seshadri completed her M.B.B.S. from the Christian Medical College, Madras University, and her M.D. in internal medicine and D.M. in neurology from the All India Institute of Medical Sciences, New Delhi, India. Additionally, she has completed a residency in neurology at the Boston University School of Medicine and a fellowship in the neurobiology of Aging and Alzheimer Disease at the University of Massachusetts Medical Center. She has previously worked as assistant professor of neurology at the All India Institute of Medical Sciences and professor of neurology and attending neurologist at the Boston University School of Medicine.
As founding director of theGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, Dr.Seshadri will oversee, integrate, and coordinate all activities of the Biggs Institute, which will share the space of UT HealthsBarshop Institute for Longevity and Aging Studies.
Dr. Seshadri enjoys a superb reputation in both science and clinical care and is a recognized thought leader in Alzheimers disease having recently co-authored position papers disseminated by the National Academy of Sciences onPreventing Cognitive Decline and Dementia: A Way Forward,and by the American Heart Association with a paper titledDefining Optimal Brain Health in Adults. She has lectured extensively, nationally and internationally, on Alzheimers disease, dementia and the genetics of stroke and vascular brain injury.
She is a senior investigator for the seminal Framingham Heart Study, has had peer reviewed research continuously funded by the National Institutes of Health for 10 years, and currently serves as the principal investigator on eight NIH U01 or R01 grants.

• Texas Matters: Alzheimer's Disease And Latinos
• Rapamycin May Slow Alzheimer’s Disease
• Study: Rapamycin prevents age-related brain vascular deterioration
• Largest study of CTE finds it in 6% of subjects
• Inflammatory marker linked to dementia
• Genes, cardiovascular health each factor into dementia risk